MyFinsight
Home
Blog
About
Exchange rate impact on
cash
$57K
(-87.42%↓ Y/Y)
Decrease in cash and cash
equivalents
-$2,608K
(34.67%↑ Y/Y)
Canceled cashflow
$57K
Notes receivable
$169K
(-48.48%↓ Y/Y)
Proceeds from employee
stock purchase...
$198K
(-24.14%↓ Y/Y)
Proceeds from exercises
of equity awards
$12K
Net income (loss)
$3,309K
(137.42%↑ Y/Y)
Stock-based compensation
expense
$1,833K
(-66.12%↓ Y/Y)
Provision for inventory
$1,543K
(-59.84%↓ Y/Y)
Depreciation
$1,505K
(-43.48%↓ Y/Y)
Prepaid expenses, other
current and long-term...
-$897K
(-12.55%↓ Y/Y)
Non-cash operating lease
cost
$465K
(-56.42%↓ Y/Y)
Accrued expenses, other
current and long-term...
$265K
(105.05%↑ Y/Y)
Deferred income taxes
$129K
(760.00%↑ Y/Y)
Net cash used in by
investing activities
-$1,280K
(-212.97%↓ Y/Y)
Net cash used in
financing activities
-$701K
(86.67%↑ Y/Y)
Net cash used in
operating activities
-$684K
(-114.42%↓ Y/Y)
Canceled cashflow
$169K
Canceled cashflow
$210K
Canceled cashflow
$9,946K
Purchases of property and
equipment
$1,449K
(-66.23%↓ Y/Y)
Repurchases of common stock
$853K
(-78.52%↓ Y/Y)
Inventories
$6,013K
(367.01%↑ Y/Y)
Cash paid for tax
withheld on vested...
$58K
(-96.26%↓ Y/Y)
Accounts receivable
$3,228K
(589.83%↑ Y/Y)
Accounts payable
-$575K
(46.06%↑ Y/Y)
Operating lease
liabilities
-$469K
(55.12%↑ Y/Y)
Interest income on notes
receivable
$175K
(-49.28%↓ Y/Y)
Provision for credit
losses
-$73K
(-154.89%↓ Y/Y)
Income taxes
-$65K
(85.49%↑ Y/Y)
Gain on sale of assets
$32K
(-93.66%↓ Y/Y)
Back
Back
Cash Flow
Anika Therapeutics, Inc. (ANIK)
Anika Therapeutics, Inc. (ANIK)
source: myfinsight.com